Work

Supplementary Table 2 from Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 2 from Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer

DOI: 10.1158/0008-5472.22371174.v1

Authors: Christine L. Hann, Vincent C. Daniel, Elizabeth A. Sugar, Irina Dobromilskaya, Sara C. Murphy, Leslie Cope, Xue Lin, Jared S. Hierman, Daniel L. Wilburn, D. Neil Watkins, Charles M. Rudin

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361892295

Cites:

Cited by:

Related to: 10